Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

Revenue ($bn), 2005–2010 52

Figure 23: Osteoporosis Therapeutics Market, Japan, Forecast ($bn), 2010–2018 53

Figure 24: Opportunity and Unmet Need in the Osteoporosis Therapeutics Market 59

Figure 25: Strategic Competitor Assessment of the Marketed Products in Osteoporosis Therapeutics, 2011 63

Figure 26: Osteoporosis Therapeutics Pipeline by Phase of Clinical Development, 2011 83

Figure 27: Osteoporosis Therapeutics Market, Global, Pipeline by Mechanism of Action (%), 2011 88

Figure 28: Technology Trends Analytics Framework, 2011 89

Figure 29: Technology Trends Analytics Frame Work – Description, 2011 89

Figure 30: Osteoporosis Therapeutics, Global, Clinical Trials by Country, 2011 101

Figure 31: Osteoporosis Therapeutics, Global, Clinical Trials by Phase (%), 2011 102

Figure 32: Osteoporosis Therapeutics, Global, Clinical Trials by Status of Development (%), 2011 103

Figure 33: Osteoporosis Therapeutics, Global, Prominent Sponsors (%), 2011 104

Figure 34: Osteoporosis Therapeutics, Global, Overall Sponsors (%), 2011 106

Figure 35: Osteoporosis Therapeutics, Global, Top Ten Companies by Phase, 2011 107

Figure 36: Osteoporosis Therapeutics Market, Drivers and Restraints, 2011 108

Figure 37: Implications for Future Market Competition in the Osteoporosis Therapeutics Market, 2011 109

Figure 38: Osteoporosis Therapeutics Market, Global, Future Players, 2011 111

Figure 39: GlobalData Market Forecasting Model 148Amgen Inc.

Astellas Pharma, Inc.

EffRx, Inc.

Merck & Co., Inc.

Novartis AG

Osteologix, Inc.

Pfizer Inc.

Radius Health, Inc

Tarsa Inc.

Zyduscadila Inc.

To order this report:

Pathology Industry:

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... Antigen Discovery Inc. (ADi), a privately held ... the receipt of a National Institutes of Health (NIH) ... Institute of Dental and Craniofacial Research (NIDCR). The one-year ... Protein Microarray Chip, which will contain every protein in ... in the development of safe and effective vaccines and ...
(Date:10/22/2014)... Oct. 22, 2014   Reproductive Medicine Associates ... in the field of infertility, presents new clinical ... screening. The research abstract, released during the 70 ... (ASRM) meeting in Honolulu, Hawaii ... gene defect (SGD) pre-implantation genetic diagnosis (PGD). ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
... NEW ORLEANS, Feb. 17, 2012  New research looks at whether clot-busting ... research was released today and will be presented at the ... April 21 to April 28, 2012. In adults, the ... after stroke symptoms begin. But few studies have looked at whether ...
... Pharmos Corporation (OTC-PINK: PARS) today reported financial results for ... These results are included in the Company,s Yearly Report on ... Fourth Quarter Ended December 31, 2011The Company recorded ... for the fourth quarter 2011 compared to a net loss ...
Cached Medicine Technology:Is Clot-Busting Drug Safe for Kids with Strokes? 2Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 2Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 3Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 4Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 5
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a ... of bacterial infections, microbial biofilms, and chronic wounds, announced ... of directors. , Dr. Sinskey is ... Massachusetts Institute of Technology, or MIT. He has been ... Sinskey also holds positions as Co-Director of the Malaysia-MIT ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/20/2014)... Orlando, Florida (PRWEB) October 20, 2014 ... fired-up former Gov. Charlie Crist made a brief fundraising ...  in Orlando on Thursday. , Fresh from a debate ... refused to take the stage for the first seven ... podium, the former governor described the incident in one ...
(Date:10/20/2014)... T.E.N., a technology and information ... that William H. Murray, renowned author and industry ... Leadership Award winner. Presented annually, the ISE® Luminary ... leader and industry practitioner for his or her ... information security industry. , Formerly with IBM, Murray ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... (HealthDay News) -- Abnormalities identified on the right side of ... and lungs, according to new research. In conducting ... or lower right chamber, researchers found that the size and ... differs, depending on their age, gender and race or ethnicity. ...
... plans to divert more mentally ill people out of the ... to be achieved, according to new research from Queen Mary, ... International Journal of Law and Psychiatry , researchers estimate that ... in prisons in England and Wales. If transferred to hospital, ...
... increasingly more common disease striking overweight, younger women is ... University, where an osteopathic physician is testing the effectiveness ... Idiopathic intracranial hypertension, known as IIH or pseudo-tumor ... around the brain, specifically in the absence of a ...
... WASHINGTON, DC, June 7, 2011 A new study ... while family members often provide critical support, they also ... impede the recovery of mentally ill relatives. "Negative ... the ways that mentally ill persons view themselves, adversely ...
... 6, 2011 An analysis linking federal bankruptcy court ... cancer cases in western Washington during a 14-year period ... increase along with the length of survival. "Patients ... to income loss and out-of-pocket costs associated with their ...
... undergo elective total hip or total knee arthroplasty at ... of venous thromboembolism and mortality following the procedure. The ... be reduced by modifying systems and procedures used before ... in Arthritis & Rheumatism , a peer-reviewed journal ...
Cached Medicine News:Health News:Right Side of Heart Linked to Lung Diseases, Study Finds 2Health News:Researcher tests drug's impact on neurological disease affecting women 2Health News:Study: What mom thinks matters when it comes to mental illness 2Health News:Study finds bankruptcy rates among cancer patients increase along with survival time 2Health News:Joint replacement surgery riskier at hospitals with low surgical volume 2
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
The miniSPO 2 T has the same advanced DOX digital technology as our multiple parameter vital signs monitors and lets you evaluate oxygen saturation and heart rate in a broad range of patients, from n...
Rad-5 signal extraction pulse oximeter™...
... Digital Handheld Pulse Oximeter provides ... patients monitoring - from spot ... the first pocket-size, handheld oximeter, ... for durability and enduring performance ...
Medicine Products: